AXIM Biotechnologies CEO Issues Letter to Shareholders
Summary: AXIM places strategic focus on commercializing FDA-cleared Dry Eye Disease (DED) diagnostic system Plans…
News
CinCor Pharma to Participate in Jefferies Biotech on the Bay Summit
WALTHAM, Mass., April 19, 2022 (GLOBE NEWSWIRE) — CinCor Pharma, Inc. (“CinCor”) today announced its participation…
Finch Therapeutics Announces Workforce Restructuring to Focus Resources on Key Development Programs
SOMERVILLE, Mass., April 19, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
Akoya Biosciences Announces Ehab A. El-Gabry, MD, as Chief Medical Officer
Dr. El-Gabry’s extensive leadership experience will be critical to accelerating Akoya’s groundbreaking spatial biomarker research…
TRACON Pharmaceuticals Announces Amended ENVASARC Protocol Approved and Open at all 30 Clinical Sites in the U.S. and U.K.
Expects to Report Results of Independent Data Monitoring Committee (IDMC) Mandated Interim Safety Reviews and…
Ceapro Inc. Announces Appointment of Geneviève Foster to Board of Directors
Accomplished business executive and attorney with diverse industry experience including over 20 years in life…
Freeline Appoints Paul Schneider as Chief Financial Officer
Biotech executive with robust experience in financial and corporate strategy and operational excellence will strengthen…
Aeterna Zentaris Secures New European Patent Related to Use of Macimorelin for the Diagnosis of Growth Hormone Deficiency in Adults
– Strengthens intellectual property portfolio for macimorelin and the commercial product Ghryvelin®/ Macrilen™in Europe as…
Cocrystal Pharma to Present at the Life Science Innovation Northwest 2022 Conference
BOTHELL, Wash., April 19, 2022 (GLOBE NEWSWIRE) — Cocrystal Pharma, Inc. (Nasdaq: COCP) announces that…
Syneos Health Promotes Baba Shetty to President, Technology and Data Solutions, and Suma Ramadas to Executive Vice President, Medical Affairs
MORRISVILLE, N.C., April 19, 2022 (GLOBE NEWSWIRE) — Syneos Health® (Nasdaq:SYNH), the only fully integrated…
Kymera Therapeutics to Report First Quarter 2022 Results and Announces Participation at Upcoming Investor Conferences
Company to begin hosting quarterly calls to provide broad updates across pipeline WATERTOWN, Mass., April…
Eyenovia Announces Poster Presentation at the 2022 American Society of Cataract and Refractive Surgery Annual Meeting
Results of “SPEED” study confirm the speed of diagnostic effectiveness of a single microdose array…
PDS Biotech Receives $1.2 Million After Selling Its Net Operating Loss Tax Benefits Through The New Jersey Economic Development Program
FLORHAM PARK, N.J., April 19, 2022 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB), a…
TFF Pharmaceuticals Announces Safety and Pharmacokinetic Data from Phase 1 Study of Niclosamide Inhalation Powder
Niclosamide Inhalation Powder Well Tolerated with No Serious Adverse Events Across All Subject Cohorts Current…
Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test
Approval adds HPV to menu of tests available on Enzo’s GenFlex® platform, which includes COVID-19…
Ocuphire Appoints Jay Pepose, M.D., Ph.D., as Chief Medical Advisor and Announces Upcoming Presentations at ASCRS 2022 and Eyecelerator
Three ASCRS presentations will feature data from Nyxol® clinical studies: second Phase 3 MIRA-3 trial…
Oyster Point Pharma to Present New Clinical Data at the American Society of Cataract and Refractive Surgery (ASCRS) 2022
PRINCETON, N.J., April 19, 2022 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a…
Innovative Cellular Therapeutics (ICT) Receives FDA Fast Track Designation for GCC19CART, its Lead Solid Tumor Candidate, in the Treatment of Patients with Relapsed or Refractory Metastatic Colorectal Cancer
GCC19CART is an autologous CAR T therapy candidate that has shown promising results in over…
Clover Presents Updated Durability and Booster Data for COVID-19 Vaccine Candidate at World Vaccine Congress Washington 2022
SHANGHAI, China, April 19, 2022 (GLOBE NEWSWIRE) — Clover Biopharmaceuticals, Ltd. (Clover; HKEX: 02197), a…
HCW Biologics’ CEO Hing C. Wong, Ph.D., to be Featured Speaker at the Third Annual International Conference on Cell and Experimental Biology 2022
Preclinical data for lead investigational drug, HCW9218, in treatment of therapy-induced senescence in cancer Debut of…